What top creators are saying about Erasca, Inc.(ERAS)

Clinical-stage biotechnology company developing cancer therapies.

1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 1 scored insight about Erasca, Inc..

Mixed
avg +0.00
0 bullish1 neutral0 bearish

Top creators covering Erasca, Inc. (ERAS)

The 1 sources with the most insights about Erasca, Inc. on Kazuha.

Latest insights about Erasca, Inc. (ERAS)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Yesterday

Neutral

Mentioned among biotech fund holdings; no company-specific investment analysis was provided.

Discussed alongside Erasca, Inc. (ERAS)

Other assets that creators frequently mention in the same content as Erasca, Inc..

Frequently asked

Which podcasters and creators cover Erasca, Inc. (ERAS) the most?

The most active sources covering Erasca, Inc. (ERAS) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Erasca, Inc. (ERAS) are on Kazuha?

Kazuha has indexed 1 AI-extracted insight about Erasca, Inc. (ERAS) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Erasca, Inc. (ERAS)?

Creators covering Erasca, Inc. (ERAS) most frequently also discuss BHVN, SFTBY, LEGN, CGON, ACAD. See the "Discussed alongside" section above for full asset pages.